nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—PTGS1—malignant glioma	0.687	1	CbGaD
Sulfamethoxazole—CYP3A4—Temozolomide—malignant glioma	0.0253	1	CbGbCtD
Sulfamethoxazole—NAT2—pineal body—malignant glioma	0.0235	0.352	CbGeAlD
Sulfamethoxazole—NAT1—pineal body—malignant glioma	0.0214	0.32	CbGeAlD
Sulfamethoxazole—NAT1—retina—malignant glioma	0.00645	0.0963	CbGeAlD
Sulfamethoxazole—Nephrotoxicity—Carmustine—malignant glioma	0.00611	0.0596	CcSEcCtD
Sulfamethoxazole—NAT1—medulla oblongata—malignant glioma	0.00466	0.0696	CbGeAlD
Sulfamethoxazole—Lung infiltration—Carmustine—malignant glioma	0.00415	0.0404	CcSEcCtD
Sulfamethoxazole—Nephropathy toxic—Carmustine—malignant glioma	0.00339	0.033	CcSEcCtD
Sulfamethoxazole—Digestion impaired—Temozolomide—malignant glioma	0.00281	0.0274	CcSEcCtD
Sulfamethoxazole—NAT1—brain—malignant glioma	0.00268	0.04	CbGeAlD
Sulfamethoxazole—Apathy—Temozolomide—malignant glioma	0.00263	0.0256	CcSEcCtD
Sulfamethoxazole—Flat affect—Temozolomide—malignant glioma	0.00261	0.0254	CcSEcCtD
Sulfamethoxazole—PTGS1—endothelium—malignant glioma	0.00207	0.0309	CbGeAlD
Sulfamethoxazole—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00199	0.0194	CcSEcCtD
Sulfamethoxazole—PTGS1—blood vessel—malignant glioma	0.00191	0.0285	CbGeAlD
Sulfamethoxazole—Aplastic anaemia—Temozolomide—malignant glioma	0.00176	0.0172	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Temozolomide—malignant glioma	0.00152	0.0149	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00145	0.0141	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Carmustine—malignant glioma	0.00142	0.0138	CcSEcCtD
Sulfamethoxazole—Purpura—Temozolomide—malignant glioma	0.00142	0.0138	CcSEcCtD
Sulfamethoxazole—Ataxia—Carmustine—malignant glioma	0.00133	0.0129	CcSEcCtD
Sulfamethoxazole—Ataxia—Temozolomide—malignant glioma	0.00128	0.0125	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00123	0.012	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Carmustine—malignant glioma	0.00116	0.0113	CcSEcCtD
Sulfamethoxazole—Neutropenia—Carmustine—malignant glioma	0.00114	0.0111	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Temozolomide—malignant glioma	0.00112	0.0109	CcSEcCtD
Sulfamethoxazole—Neutropenia—Temozolomide—malignant glioma	0.0011	0.0107	CcSEcCtD
Sulfamethoxazole—Pneumonia—Carmustine—malignant glioma	0.00109	0.0107	CcSEcCtD
Sulfamethoxazole—Depression—Carmustine—malignant glioma	0.00108	0.0106	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Temozolomide—malignant glioma	0.00108	0.0105	CcSEcCtD
Sulfamethoxazole—Renal failure—Carmustine—malignant glioma	0.00107	0.0104	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Carmustine—malignant glioma	0.00107	0.0104	CcSEcCtD
Sulfamethoxazole—Stomatitis—Carmustine—malignant glioma	0.00106	0.0103	CcSEcCtD
Sulfamethoxazole—Pneumonia—Temozolomide—malignant glioma	0.00106	0.0103	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Temozolomide—malignant glioma	0.00105	0.0102	CcSEcCtD
Sulfamethoxazole—Infestation—Temozolomide—malignant glioma	0.00105	0.0102	CcSEcCtD
Sulfamethoxazole—Depression—Temozolomide—malignant glioma	0.00105	0.0102	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00104	0.0102	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Temozolomide—malignant glioma	0.00103	0.01	CcSEcCtD
Sulfamethoxazole—Stomatitis—Temozolomide—malignant glioma	0.00102	0.00999	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Temozolomide—malignant glioma	0.000994	0.00969	CcSEcCtD
Sulfamethoxazole—Hallucination—Carmustine—malignant glioma	0.000972	0.00947	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Carmustine—malignant glioma	0.00096	0.00935	CcSEcCtD
Sulfamethoxazole—Hepatitis—Temozolomide—malignant glioma	0.000944	0.0092	CcSEcCtD
Sulfamethoxazole—Hallucination—Temozolomide—malignant glioma	0.000939	0.00915	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Temozolomide—malignant glioma	0.000932	0.00908	CcSEcCtD
Sulfamethoxazole—Sulfaphenazole—CYP2B6—malignant glioma	0.00093	0.388	CrCbGaD
Sulfamethoxazole—Connective tissue disorder—Temozolomide—malignant glioma	0.000927	0.00904	CcSEcCtD
Sulfamethoxazole—PTGS1—telencephalon—malignant glioma	0.000925	0.0138	CbGeAlD
Sulfamethoxazole—Urethral disorder—Temozolomide—malignant glioma	0.000925	0.00902	CcSEcCtD
Sulfamethoxazole—Eye disorder—Carmustine—malignant glioma	0.000913	0.0089	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Temozolomide—malignant glioma	0.000892	0.0087	CcSEcCtD
Sulfamethoxazole—Eye disorder—Temozolomide—malignant glioma	0.000882	0.0086	CcSEcCtD
Sulfamethoxazole—Tinnitus—Temozolomide—malignant glioma	0.00088	0.00858	CcSEcCtD
Sulfamethoxazole—Mental disorder—Carmustine—malignant glioma	0.000855	0.00834	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Temozolomide—malignant glioma	0.000852	0.00831	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Temozolomide—malignant glioma	0.00085	0.00829	CcSEcCtD
Sulfamethoxazole—Malnutrition—Carmustine—malignant glioma	0.00085	0.00829	CcSEcCtD
Sulfamethoxazole—Chills—Temozolomide—malignant glioma	0.000847	0.00825	CcSEcCtD
Sulfamethoxazole—Dapsone—CYP2C18—malignant glioma	0.00083	0.346	CrCbGaD
Sulfamethoxazole—Mental disorder—Temozolomide—malignant glioma	0.000827	0.00806	CcSEcCtD
Sulfamethoxazole—Malnutrition—Temozolomide—malignant glioma	0.000821	0.00801	CcSEcCtD
Sulfamethoxazole—Leukopenia—Carmustine—malignant glioma	0.000761	0.00742	CcSEcCtD
Sulfamethoxazole—Angioedema—Temozolomide—malignant glioma	0.000751	0.00732	CcSEcCtD
Sulfamethoxazole—Vertigo—Temozolomide—malignant glioma	0.000738	0.00719	CcSEcCtD
Sulfamethoxazole—Convulsion—Carmustine—malignant glioma	0.000736	0.00718	CcSEcCtD
Sulfamethoxazole—Leukopenia—Temozolomide—malignant glioma	0.000735	0.00717	CcSEcCtD
Sulfamethoxazole—ALB—brain—malignant glioma	0.000733	0.0109	CbGeAlD
Sulfamethoxazole—Myalgia—Carmustine—malignant glioma	0.000724	0.00705	CcSEcCtD
Sulfamethoxazole—Cough—Temozolomide—malignant glioma	0.000717	0.00699	CcSEcCtD
Sulfamethoxazole—Convulsion—Temozolomide—malignant glioma	0.000712	0.00694	CcSEcCtD
Sulfamethoxazole—Arthralgia—Temozolomide—malignant glioma	0.000699	0.00682	CcSEcCtD
Sulfamethoxazole—Myalgia—Temozolomide—malignant glioma	0.000699	0.00682	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000695	0.00677	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Carmustine—malignant glioma	0.000679	0.00662	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Temozolomide—malignant glioma	0.00067	0.00654	CcSEcCtD
Sulfamethoxazole—Anorexia—Carmustine—malignant glioma	0.000661	0.00645	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Temozolomide—malignant glioma	0.000657	0.00641	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Temozolomide—malignant glioma	0.000656	0.0064	CcSEcCtD
Sulfamethoxazole—Skin disorder—Temozolomide—malignant glioma	0.000651	0.00635	CcSEcCtD
Sulfamethoxazole—PTGS1—spinal cord—malignant glioma	0.000648	0.00969	CbGeAlD
Sulfamethoxazole—Anorexia—Temozolomide—malignant glioma	0.000639	0.00623	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000632	0.00616	CcSEcCtD
Sulfamethoxazole—Insomnia—Carmustine—malignant glioma	0.000627	0.00612	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Carmustine—malignant glioma	0.000618	0.00603	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000611	0.00595	CcSEcCtD
Sulfamethoxazole—Insomnia—Temozolomide—malignant glioma	0.000606	0.00591	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Carmustine—malignant glioma	0.000603	0.00588	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000599	0.00584	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Temozolomide—malignant glioma	0.000598	0.00583	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Temozolomide—malignant glioma	0.00059	0.00575	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Temozolomide—malignant glioma	0.000583	0.00568	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000579	0.00564	CcSEcCtD
Sulfamethoxazole—Fatigue—Temozolomide—malignant glioma	0.000578	0.00563	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Carmustine—malignant glioma	0.000567	0.00553	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Carmustine—malignant glioma	0.000548	0.00535	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Carmustine—malignant glioma	0.000548	0.00535	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000548	0.00534	CcSEcCtD
Sulfamethoxazole—Urticaria—Temozolomide—malignant glioma	0.000533	0.00519	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Temozolomide—malignant glioma	0.00053	0.00517	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Temozolomide—malignant glioma	0.00053	0.00517	CcSEcCtD
Sulfamethoxazole—PTGS1—central nervous system—malignant glioma	0.000526	0.00786	CbGeAlD
Sulfamethoxazole—CYP2C8—brain—malignant glioma	0.000515	0.00769	CbGeAlD
Sulfamethoxazole—Hypersensitivity—Carmustine—malignant glioma	0.000511	0.00498	CcSEcCtD
Sulfamethoxazole—Asthenia—Carmustine—malignant glioma	0.000498	0.00485	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Temozolomide—malignant glioma	0.000494	0.00482	CcSEcCtD
Sulfamethoxazole—Asthenia—Temozolomide—malignant glioma	0.000481	0.00469	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Carmustine—malignant glioma	0.000475	0.00463	CcSEcCtD
Sulfamethoxazole—Pruritus—Temozolomide—malignant glioma	0.000474	0.00462	CcSEcCtD
Sulfamethoxazole—Dizziness—Carmustine—malignant glioma	0.000459	0.00447	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Temozolomide—malignant glioma	0.000459	0.00447	CcSEcCtD
Sulfamethoxazole—Dizziness—Temozolomide—malignant glioma	0.000443	0.00432	CcSEcCtD
Sulfamethoxazole—Vomiting—Carmustine—malignant glioma	0.000441	0.0043	CcSEcCtD
Sulfamethoxazole—CYP3A4—central nervous system—malignant glioma	0.000439	0.00656	CbGeAlD
Sulfamethoxazole—Rash—Carmustine—malignant glioma	0.000437	0.00426	CcSEcCtD
Sulfamethoxazole—Dermatitis—Carmustine—malignant glioma	0.000437	0.00426	CcSEcCtD
Sulfamethoxazole—Headache—Carmustine—malignant glioma	0.000435	0.00424	CcSEcCtD
Sulfamethoxazole—Vomiting—Temozolomide—malignant glioma	0.000426	0.00416	CcSEcCtD
Sulfamethoxazole—Rash—Temozolomide—malignant glioma	0.000423	0.00412	CcSEcCtD
Sulfamethoxazole—Dermatitis—Temozolomide—malignant glioma	0.000422	0.00412	CcSEcCtD
Sulfamethoxazole—Headache—Temozolomide—malignant glioma	0.00042	0.00409	CcSEcCtD
Sulfamethoxazole—PTGS1—brain—malignant glioma	0.000418	0.00624	CbGeAlD
Sulfamethoxazole—Nausea—Carmustine—malignant glioma	0.000412	0.00402	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS1—malignant glioma	0.000405	0.169	CrCbGaD
Sulfamethoxazole—Nausea—Temozolomide—malignant glioma	0.000398	0.00388	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—malignant glioma	0.000232	0.0967	CrCbGaD
Sulfamethoxazole—PTGS1—Metabolism—BCAN—malignant glioma	6.49e-05	0.00056	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.49e-05	0.00056	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CA—malignant glioma	6.47e-05	0.000559	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	6.44e-05	0.000556	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—IDH2—malignant glioma	6.42e-05	0.000554	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.31e-05	0.000545	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CAV1—malignant glioma	6.31e-05	0.000545	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.28e-05	0.000542	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.05e-05	0.000523	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP2B6—malignant glioma	6.03e-05	0.000521	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—malignant glioma	5.96e-05	0.000514	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	5.81e-05	0.000502	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CG—malignant glioma	5.75e-05	0.000497	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PPARG—malignant glioma	5.55e-05	0.000479	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—IDH1—malignant glioma	5.52e-05	0.000477	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TNF—malignant glioma	5.37e-05	0.000464	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SPHK1—malignant glioma	5.34e-05	0.000461	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.31e-05	0.000459	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—AKT1—malignant glioma	5.28e-05	0.000456	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—COX8A—malignant glioma	5.24e-05	0.000453	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	5.24e-05	0.000452	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	5.24e-05	0.000452	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—IDH2—malignant glioma	5.23e-05	0.000452	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP2C18—malignant glioma	5.23e-05	0.000452	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—COX8A—malignant glioma	5.21e-05	0.00045	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.14e-05	0.000444	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—H3F3A—malignant glioma	5.07e-05	0.000438	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CD—malignant glioma	5.05e-05	0.000437	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	5.01e-05	0.000433	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	4.95e-05	0.000428	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.93e-05	0.000426	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.93e-05	0.000426	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP2B6—malignant glioma	4.92e-05	0.000425	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RTEL1—malignant glioma	4.9e-05	0.000423	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.85e-05	0.000419	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.78e-05	0.000413	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.69e-05	0.000405	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.66e-05	0.000403	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	4.59e-05	0.000396	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—IDH1—malignant glioma	4.5e-05	0.000388	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.49e-05	0.000388	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ASMT—malignant glioma	4.46e-05	0.000385	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ASMT—malignant glioma	4.43e-05	0.000383	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	4.43e-05	0.000383	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	4.41e-05	0.000381	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CB—malignant glioma	4.41e-05	0.000381	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTGS2—malignant glioma	4.37e-05	0.000377	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.36e-05	0.000376	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SPHK1—malignant glioma	4.35e-05	0.000376	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.34e-05	0.000375	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.33e-05	0.000374	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—COX8A—malignant glioma	4.27e-05	0.000369	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP2C18—malignant glioma	4.26e-05	0.000368	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTT1—malignant glioma	4.23e-05	0.000365	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BCAN—malignant glioma	4.19e-05	0.000362	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KNG1—malignant glioma	4.18e-05	0.000361	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BCAN—malignant glioma	4.17e-05	0.00036	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNA2—malignant glioma	4.09e-05	0.000353	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.07e-05	0.000351	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.02e-05	0.000347	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS1—malignant glioma	3.96e-05	0.000342	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.95e-05	0.000341	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	3.93e-05	0.00034	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SOD1—malignant glioma	3.88e-05	0.000335	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.87e-05	0.000335	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	3.84e-05	0.000332	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.81e-05	0.000329	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTEN—malignant glioma	3.81e-05	0.000329	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—BCHE—malignant glioma	3.69e-05	0.000318	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.66e-05	0.000316	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SLC5A5—malignant glioma	3.64e-05	0.000314	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ASMT—malignant glioma	3.63e-05	0.000313	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PTK2—malignant glioma	3.56e-05	0.000308	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.55e-05	0.000306	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.53e-05	0.000305	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	3.53e-05	0.000305	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTT1—malignant glioma	3.45e-05	0.000298	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.44e-05	0.000297	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BCAN—malignant glioma	3.41e-05	0.000295	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.41e-05	0.000295	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—IDH2—malignant glioma	3.38e-05	0.000292	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—IDH2—malignant glioma	3.36e-05	0.00029	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.22e-05	0.000278	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.19e-05	0.000275	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2B6—malignant glioma	3.18e-05	0.000274	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.17e-05	0.000274	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2B6—malignant glioma	3.16e-05	0.000273	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—BCHE—malignant glioma	3e-05	0.000259	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	3e-05	0.000259	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PDGFB—malignant glioma	2.99e-05	0.000259	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.97e-05	0.000257	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC5A5—malignant glioma	2.97e-05	0.000256	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTP1—malignant glioma	2.93e-05	0.000253	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—IDH1—malignant glioma	2.91e-05	0.000251	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—IDH1—malignant glioma	2.89e-05	0.00025	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CAT—malignant glioma	2.85e-05	0.000246	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CAV1—malignant glioma	2.84e-05	0.000245	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—COX8A—malignant glioma	2.81e-05	0.000243	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SPHK1—malignant glioma	2.81e-05	0.000243	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.81e-05	0.000242	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SPHK1—malignant glioma	2.8e-05	0.000241	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.78e-05	0.00024	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.75e-05	0.000238	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—IDH2—malignant glioma	2.75e-05	0.000237	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2C18—malignant glioma	2.74e-05	0.000237	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—F2—malignant glioma	2.7e-05	0.000233	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—FN1—malignant glioma	2.7e-05	0.000233	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NCOR1—malignant glioma	2.69e-05	0.000233	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CA—malignant glioma	2.69e-05	0.000232	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.6e-05	0.000224	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.59e-05	0.000224	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.59e-05	0.000223	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CG—malignant glioma	2.58e-05	0.000223	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.58e-05	0.000223	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EGF—malignant glioma	2.55e-05	0.000221	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PTPN11—malignant glioma	2.54e-05	0.000219	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.42e-05	0.000209	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ASMT—malignant glioma	2.39e-05	0.000207	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTP1—malignant glioma	2.39e-05	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.37e-05	0.000204	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—IDH1—malignant glioma	2.36e-05	0.000204	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT2—malignant glioma	2.36e-05	0.000204	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.35e-05	0.000203	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	2.34e-05	0.000202	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAT—malignant glioma	2.33e-05	0.000201	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SPHK1—malignant glioma	2.29e-05	0.000198	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.28e-05	0.000197	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CD—malignant glioma	2.27e-05	0.000196	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.27e-05	0.000196	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BCAN—malignant glioma	2.25e-05	0.000194	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.24e-05	0.000194	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTT1—malignant glioma	2.23e-05	0.000192	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTT1—malignant glioma	2.21e-05	0.000191	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NCOR1—malignant glioma	2.2e-05	0.00019	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CAV1—malignant glioma	2.2e-05	0.00019	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—malignant glioma	2.19e-05	0.00019	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.11e-05	0.000183	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.1e-05	0.000181	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS1—malignant glioma	2.09e-05	0.00018	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.08e-05	0.00018	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS1—malignant glioma	2.08e-05	0.000179	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.07e-05	0.000179	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAF1—malignant glioma	2.03e-05	0.000175	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—malignant glioma	2e-05	0.000173	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CB—malignant glioma	1.98e-05	0.000171	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BCHE—malignant glioma	1.94e-05	0.000168	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARG—malignant glioma	1.93e-05	0.000167	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BCHE—malignant glioma	1.93e-05	0.000167	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.93e-05	0.000166	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.92e-05	0.000166	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.91e-05	0.000165	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC5A5—malignant glioma	1.91e-05	0.000165	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.86e-05	0.00016	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—malignant glioma	1.82e-05	0.000157	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—IDH2—malignant glioma	1.81e-05	0.000157	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—malignant glioma	1.81e-05	0.000157	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.81e-05	0.000157	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.8e-05	0.000156	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.8e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAV1—malignant glioma	1.79e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.79e-05	0.000154	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.76e-05	0.000152	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.76e-05	0.000152	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.71e-05	0.000148	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.7e-05	0.000147	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS1—malignant glioma	1.7e-05	0.000147	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.69e-05	0.000146	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—malignant glioma	1.63e-05	0.000141	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BCHE—malignant glioma	1.58e-05	0.000136	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARG—malignant glioma	1.57e-05	0.000136	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.57e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.56e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—IDH1—malignant glioma	1.56e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.56e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—malignant glioma	1.55e-05	0.000133	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—malignant glioma	1.54e-05	0.000133	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—malignant glioma	1.54e-05	0.000133	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CB—malignant glioma	1.53e-05	0.000132	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—malignant glioma	1.52e-05	0.000131	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SPHK1—malignant glioma	1.51e-05	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAT—malignant glioma	1.5e-05	0.00013	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAT—malignant glioma	1.49e-05	0.000129	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.48e-05	0.000128	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.48e-05	0.000127	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.46e-05	0.000126	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CD—malignant glioma	1.43e-05	0.000124	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NCOR1—malignant glioma	1.42e-05	0.000123	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—malignant glioma	1.32e-05	0.000114	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—malignant glioma	1.31e-05	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.27e-05	0.00011	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—malignant glioma	1.26e-05	0.000109	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CB—malignant glioma	1.25e-05	0.000108	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—malignant glioma	1.24e-05	0.000107	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAT—malignant glioma	1.22e-05	0.000106	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—malignant glioma	1.21e-05	0.000104	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—malignant glioma	1.2e-05	0.000103	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—malignant glioma	1.17e-05	0.000101	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAV1—malignant glioma	1.16e-05	9.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOR1—malignant glioma	1.15e-05	9.97e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAV1—malignant glioma	1.15e-05	9.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS1—malignant glioma	1.12e-05	9.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.1e-05	9.54e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.1e-05	9.49e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—malignant glioma	1.08e-05	9.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.05e-05	9.1e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—malignant glioma	1.05e-05	9.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BCHE—malignant glioma	1.04e-05	9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.03e-05	8.89e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARG—malignant glioma	1.02e-05	8.78e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARG—malignant glioma	1.01e-05	8.73e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—malignant glioma	9.86e-06	8.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAV1—malignant glioma	9.41e-06	8.13e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—malignant glioma	9.35e-06	8.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CD—malignant glioma	9.26e-06	8e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CD—malignant glioma	9.21e-06	7.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.99e-06	7.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	8.57e-06	7.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—malignant glioma	8.29e-06	7.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARG—malignant glioma	8.28e-06	7.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CB—malignant glioma	8.07e-06	6.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAT—malignant glioma	8.06e-06	6.97e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CB—malignant glioma	8.03e-06	6.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—malignant glioma	8e-06	6.91e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—malignant glioma	7.95e-06	6.87e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—malignant glioma	7.63e-06	6.59e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—malignant glioma	7.62e-06	6.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOR1—malignant glioma	7.62e-06	6.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	7.54e-06	6.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—malignant glioma	6.98e-06	6.03e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—malignant glioma	6.94e-06	5.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	6.57e-06	5.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—malignant glioma	6.51e-06	5.62e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—malignant glioma	6.22e-06	5.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAV1—malignant glioma	6.21e-06	5.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—malignant glioma	5.68e-06	4.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.65e-06	4.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARG—malignant glioma	5.46e-06	4.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.97e-06	4.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.92e-06	4.25e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—malignant glioma	4.89e-06	4.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.33e-06	3.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—malignant glioma	4.29e-06	3.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—malignant glioma	4.02e-06	3.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.01e-06	3.46e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—malignant glioma	4e-06	3.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—malignant glioma	3.74e-06	3.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—malignant glioma	3.27e-06	2.83e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.64e-06	2.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—malignant glioma	2.16e-06	1.86e-05	CbGpPWpGaD
